Table 1.
Clinical profile of the PC patients recruited in this study
|
Methylome group |
P |
Test group |
P | ||||
|---|---|---|---|---|---|---|---|
| Pancreatic carcinoma | Non-tumor tissue adjacent to pancreatic carcinoma | Pancreatic carcinoma | Non-tumor tissue adjacent to pancreatic carcinoma | ||||
| Number of patients |
10 |
10 |
|
16 |
15 |
|
|
| Sex | |||||||
| |
Male |
6 (60.0%) |
6 (60.0%) |
1.000 |
12 (75.0%) |
12 (75.0%) |
0.638 |
| |
Female |
4 (40.0%) |
4 (40.0%) |
4 (25.0%) |
4 (25.0%) |
||
| Age | |||||||
| |
>60 years |
7 (70.0%) |
7 (70.0%) |
1.000 |
12 (75.0%) |
12 (80.0%) |
1.000 |
| |
≤60 years |
3 (30.0% |
3 (30.0% |
4 (25.0%) |
3 (20.0%) |
||
| Tumor location | |||||||
| |
Head |
7 (70.0%) |
7 (70.0%) |
1.000 |
13 (71.2%) |
13 (86.7%) |
1.000 |
| |
Body and tail |
3 (30.0% |
3 (30.0% |
3 (18.8%) |
2 (13.3%) |
||
| Differentiation | |||||||
| |
Poor |
4 (40.0%) |
4 (40.0%) |
1.000 |
3 (37.5%) |
1 (20.0%) |
1.000 |
| |
Moderate |
6 (60.0%) |
6 (60.0%) |
5(63.5%) |
4 (80.0%) |
||
| |
High |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
||
| Tumor stage | |||||||
| |
I, II |
7 (70.0%) |
7 (70.0%) |
1.000 |
6 (75.0%) |
4 (80.0%) |
1.000 |
| |
III, IV |
3 (30.0%) |
3 (30.0%) |
2 (25.0%) |
1 (20.0%) |
||
| Tumor size | |||||||
| |
≤3 cm |
6 (60.0%) |
6 (60.0%) |
1.000 |
6 (75.0%) |
4 (80.0%) |
0.638 |
| |
>3 cm |
4 (40.0%) |
4 (40.0%) |
2 (25.0%) |
1 (20.0%) |
||
| Lymph node metastasis | |||||||
| |
Yes |
8 (80.0%) |
8 (80.0%) |
1.000 | 7 (87.5%) |
4 (80.0%) |
1.000 |
| No | 2 (20.0%) | 2 (20.0%) | 1 (12.5%) | 1 (20.0%) | |||